Clinically Significant Drug Interactions with New Immunosuppressive Agents

被引：0
|
作者：
Christian Mignat
机构：
[1] Christian Albrechts University of Kiel,Department of Pharmacology
来源：
Drug Safety | 1997年 / 16卷
关键词：
Adis International Limited; Tacrolimus; Sirolimus; Mycophenolate Mofetil; Danazol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Tacrolimus (FK506), mycophenolate mofetil, sirolimus (rapamycin), gusperimus, and monoclonal antibody preparations are new immunosuppressive agents, some of which are already approved for clinical use, while others are currently undergoing clinical trials. The present article provides an overview of adverse drug interactions between these immunosuppressants and other drugs which may be used concomitantly.
引用
收藏
页码：267 / 278
页数：11
相关论文
共 50 条
  • [11] Evidence of a clinically significant drug-drug interaction between cannabidiol and tacrolimus
    Leino, Abbie D.
    Emoto, Chie
    Fukuda, Tsuyoshi
    Privitera, Michael
    Vinks, Alexander A.
    Alloway, Rita R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (10) : 2944 - 2948
  • [12] Drug-Drug Interactions Between Antiretroviral and Immunosuppressive Agents in HIV-Infected Patients After Solid Organ Transplantation: A Review
    van Maarseveen, Erik M.
    Rogers, Christin C.
    Trofe-Clark, Jennifer
    van Zuilen, Arjan D.
    Mudrikova, Tania
    AIDS PATIENT CARE AND STDS, 2012, 26 (10) : 568 - 581
  • [13] Drug interactions of the new immunosuppressants
    Reactions Weekly, 1997, 647 (1) : 4 - 4
  • [14] Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins
    Attaphol Pawarode
    Suneet Shukla
    Hans Minderman
    Stacy M. Fricke
    Elaine M. Pinder
    Kieran L. O’Loughlin
    Suresh V. Ambudkar
    Maria R. Baer
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 179 - 188
  • [15] Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins
    Pawarode, Attaphol
    Shukla, Suneet
    Minderman, Hans
    Fricke, Stacy M.
    Pinder, Elaine M.
    O'Loughlin, Kieran L.
    Ambudkar, Suresh V.
    Baer, Maria R.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (02) : 179 - 188
  • [16] Antiretroviral and Immunosuppressive Drug-Drug Interactions in Human Immunodeficiency Virus-Infected Liver and Kidney Transplant Recipients
    Marfo, K.
    Greenstein, S.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (09) : 3796 - 3799
  • [17] Immunosuppressive agents in Dermatology
    Bressan, Aline Lopes
    da Silva, Roberto Souto
    Fontenelle, Elisa
    Gripp, Alexandre Carlos
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2010, 85 (01) : 9 - 22
  • [18] New developments in immunosuppressive therapy for heart transplantation
    Khush, Kiran K.
    Valantine, Hannah A.
    EXPERT OPINION ON EMERGING DRUGS, 2009, 14 (01) : 1 - 21
  • [19] Antiparkinsonian AgentsClinically Significant Drug Interactions and Adverse Effects, and Their Management
    Arif Dalvi
    Blair Ford
    CNS Drugs, 1998, 9 : 291 - 310
  • [20] Drug Concentration Monitoring of Immunosuppressive AgentsFocus on Tacrolimus, Mycophenolate Mofetil and Sirolimus
    Shirley M. Tsunoda
    Francesca T. Aweeka
    BioDrugs, 2000, 14 : 355 - 369
12345